Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04775836
Status:
UNKNOWN
Last Update Posted:
2021-03-01
First Post:
2021-02-05
Brief Title:
An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases
Sponsor:
Ministry of Science and Technology of the Peoples Republic of China
Organization:
Ministry of Science and Technology of the Peoples Republic of China
Study Overview
Official Title:
A Platform for Linking and Assessing To Facilitate Outcomes and Research Methods in CerebroVascular Diseases Using Electronic Health Records PLATFORM-CVD
Status:
UNKNOWN
Status Verified Date:
2021-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PLATFORM-CVD
Brief Summary:
In this protocol the investigators present methods and preliminary results from the PLATFORM-CVD Study an EHR-based multicenter cohort This study will focus on assessing the distribution of major cerebrovascular diseases determining the risk factors associated with disease incidence and worse in-hospital outcomes as well as describing the quality of care Data from this cohort will be used to develop suitable prediction models for cerebrovascular diseases using real-world data and to understand how outcomes for cerebrovascular diseases would change with quality improvement interventions
Detailed Description:
Adherence to healthcare quality measures is needed to reduce the burden of cerebrovascular disease and improve clinical outcomes Electronic health records EHRs can facilitate the standardization of care provision and the improvement of disease prediction and prevention Although the EHRs in clinical settings are increasingly prevalent in China they are rarely used for healthcare research the investigators aimed to conduct an EHR-based registry study to improve the healthcare and outcomes for cerebrovascular diseases
Twenty-four hospitals were enrolled in the PLATFORM-CVD Study in January 2018 Data collection began on February 1st 2019 Historical data from January 2017 are abstracted first and prospective data are continuously reported until May 20th 2020 Data were abstracted from the medical records including hospital information system laboratory information management system and picture archiving and communication systems by an extract-transform-load tool The EHR system included diagnostic information for cerebral infarctions I63 nontraumatic intracerebral hemorrhages I61 nontraumatic subarachnoid hemorrhages I60 transient cerebral ischemic attacks and related syndromes G45 intracranial and intraspinal phlebitis and thrombophlebitis G08 vascular dementia F01 and other aneurysms I72 The quality of stroke care was assessed by 21 evidence-based performance measures In-hospital outcomes were calculated including mortality length of stay and costs
The PLATFORM-CVD Study leverages EHRs to better understand incident cerebrovascular diseases in China Data from this cohort will serve as a unique platform for quality assessment and improvement for acute treatment and secondary prevention of cerebrovascular diseases as well as in-hospital outcome risk predictions and health economic evaluations
Twenty-four hospitals were enrolled in the PLATFORM-CVD Study in January 2018 Data collection began on February 1st 2019 Historical data from January 2017 are abstracted first and prospective data are continuously reported until May 20th 2020 Data were abstracted from the medical records including hospital information system laboratory information management system and picture archiving and communication systems by an extract-transform-load tool The EHR system included diagnostic information for cerebral infarctions I63 nontraumatic intracerebral hemorrhages I61 nontraumatic subarachnoid hemorrhages I60 transient cerebral ischemic attacks and related syndromes G45 intracranial and intraspinal phlebitis and thrombophlebitis G08 vascular dementia F01 and other aneurysms I72 The quality of stroke care was assessed by 21 evidence-based performance measures In-hospital outcomes were calculated including mortality length of stay and costs
The PLATFORM-CVD Study leverages EHRs to better understand incident cerebrovascular diseases in China Data from this cohort will serve as a unique platform for quality assessment and improvement for acute treatment and secondary prevention of cerebrovascular diseases as well as in-hospital outcome risk predictions and health economic evaluations
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None